Open Chain Chiral Macrolide Building Blocks
71
4-O-Benzyl-2-(1,3-dithian-2-yl)-1,6-anhydro-β-D-glucopyranose
(7)
To a solution of 1,3-dithiane (102 mg, 0.85 mmol) in dried THF at −20◦C
(ice/NaCl) was added n-BuLi (23% in hexane, 0.40 mL, 0.85 mmol). After stir-
ring for 1 h at −20◦C, the solution was cooled to −78◦C and the epoxide 1
(200 mg, 0.85 mmol) was added. The reaction mixture was warmed to rt and
stirred overnight. To quench the reaction, saturated NH4Cl (5 mL) was added.
The organic layer was separated and the aqueous layer was extracted with
CH2Cl2 (3 × 10 mL). The combined organic phase was dried over Na2SO4,
filtered, and concentrated under reduced pressure. The residue obtained was
purified by column chromatography (PE/EtOAc 7:3) to obtain compound 7 as
colorless oil in 71% yield (213 mg, 0.60 mmol).
[α]D = −23.3 (c 0.8, CH2Cl2). 1H NMR (500 MHz, CDCl3): δ = 1.93 (m, 1H,
2ꢁ-H), 2.00–2.10 (m, 2 H, 5ꢁ-H), 2.72–2.79 (m, 2 H, 4ꢁ-H), 2.83–2.91 (m, 2 H,
6 -H), 2.97 (d, J2 ,2 = 6.4 Hz, 1 H, 2ꢁ-H), 3.40 (brs, 1 H, 3-H), 3.68 (dd, J6a,6b
ꢁ
= 7.5 Hz, J6a,5 = 5.3 Hz, 1 H, 6a-H), 4.01 (d, J6b,6a = 7.5 Hz, 1 H, 6b-H), 4.27
(d, J4,3 = 9.9 Hz ,1 H, 4-H), 4.31 (brs, 1H, OH), 4.56 (d, J5,6a = 5.3 Hz, 1 H,
5-H), 4.61 (d, J11a,11b = 11.8 Hz, 1 H, 11a, CH2-Bn), 4.68 (d, J11b,11a = 11.8
Hz, 1 H, 11b, CH2-Bn), 5.91 (s, 1H, 1-H), 7.26–7.37 (m, 5H, Ar-H). 13C NMR
(125 MHz, CDCl3): δ = 25.7 (t, C-5ꢁ), 28.5 (t, C-4ꢁ), 28.9 (t, C-6ꢁ), 45.4 (d, C-2ꢁ),
48.7 (d, C-2), 66.4 (t, C-6), 67.1 (d, C-3), 71.7 (t, C-11, CH2-OBn), 75.5 (d, C-5),
79.6 (d, C-4), 101.4 (d, C-1), 127.8 (d, C-Ar), 127.9 (d, C-Ar), 128.0 (d, C-Ar),
128.3 (d, C-Ar), 128.4 (d, C-Ar), 137.8 (s, C-Ar). IR (Film): ν˜ =3444 (brs, O−H),
2896 (C−H), 1619 (C−H), 1454 (C-H), 1461 (C−H), 1371 (C−H), 1276 (C−O),
1039 (C−O). MS (EI, 70 eV): m/z (%) = 354 (14) [M+], 308 (2), 263 (10), 234
(26), 217 (4), 161 (10), 119 (96), 91 (100), 47 (14), 35 (6). HREIMS: Calc. for
C17H22O4S2 354.09595. Found 354.09605.
(2R,3S,4R)-3-(Benzyloxy)-5,5-di(1,3-dithian-2-yl)pentane-1,2,4-
triol (8)
The reaction was carried out according to the procedure as described for
compound 6. Dithiane 7 (100 mg, 0.28 mmol) in CH2Cl2 (10 mL) was re-
acted with 1,3-propanedithiol (0.042 mL, 0.42 mmol, 1.5 eq.) and BF3-Et2O
(0.075 mL, 0.60 mmol, 2.1 eq.) to afford triol 8 (91 mg, 0.20 mmol, 68% yield).
m.p = 64–65◦C. [α]D = −10.7 (c 0.9, CH2Cl2). 1H NMR (500 MHz, CDCl3):
δ = 1.84 (m, 2 H, 5ꢁ-H), 2.05 (m, 2 H, 5ꢁ-H), 2.38 (m, 1 H, 5-H), 2.71–3.05 (m,
8 H, 4ꢁ-H, 4ꢁꢁ-H, 6ꢁ-H, 6ꢁꢁ-H), 3.41 (brs, 1 H, OH), 3.72 (m, 1 H, 1a-H), 3.82 (m,
1 H, 1b-H), 4.13 (m, 2 H, 2-H,3-H), 4.58 (d, J2 ,5 = 1.8 Hz, 1 H, 2ꢁ-H), 4.75 (d,
ꢁ
J2 ,5 = 1.8 Hz, 1 H, 2ꢁꢁ-H), 4.78 (s, 2H, CH2-Bn), 7.26–7.39 (m, 5H, Ar-H). 13C
ꢁꢁ
NMR (125 MHz, CDCl3): δ = 25.8 (t, C-5ꢁ), 25.9 (t, C-5ꢁꢁ), 31.3 (t, C-4ꢁ), 31.4 (t,
C-4ꢁꢁ, 31.7 (t, C-6ꢁ), 32.2 (t, C-6ꢁꢁ), 48.6 (d, C-2ꢁ) , 49.9 (d, C-2ꢁꢁ), 51.8 (d, C-5),